NCT06089824View on ClinicalTrials.gov

Drug Utilisation of Mysimba/Contrave

CompletedOBSERVATIONAL
Enrollment

43,324

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Obesity
Trial Locations (1)

37208

Currax Pharmaceuticals, Nashville

Sponsors
All Listed Sponsors
lead

Currax Pharmaceuticals

INDUSTRY

NCT06089824 - Drug Utilisation of Mysimba/Contrave | Biotech Hunter | Biotech Hunter